MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 10, 2007; DOI: 10.1124/mol.107.034868


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.034868v1
72/3/665    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pannaccione, A.
Right arrow Articles by Annunziato, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pannaccione, A.
Right arrow Articles by Annunziato, L.


Received for publication February 8, 2007.
Revised May 10, 2007.
Accepted for publication May 10, 2007.

Up-regulation and increased activity of KV3.4 channels and its accessory subunit MIRP2 induced by amyloid peptide is involved in apoptotic neuronal death

Anna Pannaccione 1, Francesca Boscia 1, Antonella Scorziello 1, Annagrazia Adornetto 1, Pasqualina Castaldo 1, Rossana Sirabella 1, Maurizio Taglialatela 1, Gianfranco Di Renzo 1, Lucio Annunziato 1*

1 Division of Pharmacology, Department of Neuroscience, School of Medicine,

* Address correspondence to: E-mail: lannunzi{at}unina.it

Abstract

The aim of the present study was to investigate whether KV3.4 channel subunits are involved in neuronal death induced by neurotoxic {beta}-amyloid peptides (A{beta}). Particularly, to test this hypothesis, three main questions were addressed: (1) whether the A{beta} peptide can up-regulate both the transcription/translocation and activity of KV3.4 channel subunit, as well as its accessory subunit MIRP2; (2) whether the increase in KV3.4 expression and activity can be mediated by the NF-kB family of transcriptional factors; (3) whether the specific inhibition of KV3.4 channel subunit reverts the A{beta}fnpeptide-induced neurodegeneration in hippocampal neurons and NGF-differentiated PC-12 cells. We found that A{beta}1-42 treatment induced an increase in KV3.4 and MIRP-2 transcripts and proteins, detected by RT-PCR and by Western blot analysis, in NGF-differentiated PC-12 cells and hippocampal neurons. Patch-clamp experiments performed in whole cell configuration revealed that the A{beta} peptide caused an increase in IA current amplitude carried by KV3.4 channel subunits, as revealed by their specific blockade with BDS-I both in hippocampal neurons and NGF-differentiated PC-12 cells. The inhibition of NF-kB nuclear translocation with the cell-membrane permeable peptide SN-50 prevented the increase in KV3.4 protein and transcript expression. In addition, the SN-50 able to block A{beta}1-42-induced increase in KV3.4 K+ currents and to prevent cell death caused by A{beta}1-42 exposure. Finally, BDS-I toxin produced a similar neuroprotective effect by inhibiting the increase in KV3.4 expression. Collectively, our data indicate that KV3.4 channels could be a novel target for therapeutic strategy of AD.


Key words: Ion channel regulation, Potassium, NFkappaB, Fluorescence techniques, Immunocytochemistry


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
E. Choi and G. W. Abbott
The MiRP2-Kv3.4 Potassium Channel: Muscling In on Alzheimer's Disease
Mol. Pharmacol., September 1, 2007; 72(3): 499 - 501.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics